glp-1 white house The aggressively denied a report that implied President Trump may have received the investigational obesity medication retatrutide. "Because this has to be spelled out for [Lizzy Lawrence], who has proven Trump, Eli Lilly, Novo Nordisk
Description
Some patients are reporting breakoutsbut clinical research tells a different story
![glp-1 white house The aggressively denied a report that implied President Trump may have received the investigational obesity medication retatrutide. "Because this has to be spelled out for [Lizzy Lawrence], who has proven Trump, Eli Lilly, Novo Nordisk](https://image.cnbcfm.com/api/v1/image/108222515-1762450057761-gettyimages-2245349348-ah700100_ppd4zeto.jpeg?v=1770321197&w=720&h=405)
90-Day Real Results Promise
![glp-1 white house The aggressively denied a report that implied President Trump may have received the investigational obesity medication retatrutide. "Because this has to be spelled out for [Lizzy Lawrence], who has proven Trump, Eli Lilly, Novo Nordisk](https://qtxasset.com/cdn-cgi/image/w=384,h=216,f=auto,fit=crop,g=0.5x0.5/https://qtxasset.com/quartz/qcloud5/media/image/Featured%20Images%20-%20Fierce%20Healthcare%20-%202025-01-17T060956.289.jpg?VersionId=7lqDaRG_id08agwiginsCp7kjJ9_GaKM)
The conversation around it has grown, especially online,
![glp-1 white house The aggressively denied a report that implied President Trump may have received the investigational obesity medication retatrutide. "Because this has to be spelled out for [Lizzy Lawrence], who has proven Trump, Eli Lilly, Novo Nordisk](https://assets.newsweek.com/wp-content/uploads/2025/12/GettyImages-2245350681.jpg?w=1600&quality=80&webp=1)
*Daily Value not established
![glp-1 white house The aggressively denied a report that implied President Trump may have received the investigational obesity medication retatrutide. "Because this has to be spelled out for [Lizzy Lawrence], who has proven Trump, Eli Lilly, Novo Nordisk](https://lookaside.instagram.com/seo/google_widget/crawler/?media_id=3761414306701834783)
23, 2024 (HealthDay News) -- The U.S
![glp-1 white house The aggressively denied a report that implied President Trump may have received the investigational obesity medication retatrutide. "Because this has to be spelled out for [Lizzy Lawrence], who has proven Trump, Eli Lilly, Novo Nordisk](https://static.biospace.com/dims4/default/4dc6217/2147483647/strip/true/crop/905x510+0+0/resize/1000x563!/quality/90/?url=https%3A%2F%2Fstatic.biospace.com%2Ff0%2F25%2F2f8382cb4f718c22b6197571e997%2Fricks-cropped.png)
Semaglutide (Ozempic) stimulates insulin production, helping balance blood glucose levels and reducing appetite
![glp-1 white house The aggressively denied a report that implied President Trump may have received the investigational obesity medication retatrutide. "Because this has to be spelled out for [Lizzy Lawrence], who has proven Trump, Eli Lilly, Novo Nordisk](https://images.everydayhealth.com/images/2025/trump-weight-loss-drug-deal-medicare-coverage-lower-prices-1440x810.jpg?w=576)
